Compare ATO & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATO | LH |
|---|---|---|
| Founded | 1906 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Oil/Gas Transmission | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.8B | 25.9B |
| IPO Year | 1994 | 2005 |
| Metric | ATO | LH |
|---|---|---|
| Price | $170.22 | $324.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $182.25 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 918.4K | 735.8K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.15% | 1.12% |
| EPS Growth | 9.22 | ★ 18.33 |
| EPS | ★ 7.33 | 6.99 |
| Revenue | $4,702,755,000.00 | ★ $13,951,700,000.00 |
| Revenue This Year | $15.32 | $8.26 |
| Revenue Next Year | $10.09 | $4.81 |
| P/E Ratio | ★ $23.18 | $45.51 |
| Revenue Growth | ★ 12.91 | 7.25 |
| 52 Week Low | $160.10 | $244.52 |
| 52 Week High | $192.51 | $325.58 |
| Indicator | ATO | LH |
|---|---|---|
| Relative Strength Index (RSI) | 40.17 | 70.16 |
| Support Level | $165.47 | $251.37 |
| Resistance Level | $171.21 | N/A |
| Average True Range (ATR) | 2.91 | 8.08 |
| MACD | -0.46 | 0.01 |
| Stochastic Oscillator | 20.07 | 93.53 |
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3.3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.